Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention

被引:183
作者
Reinehr, Thomas
de Sousa, Gideon
Toschke, Andre Michael
Andler, Werner
机构
[1] Univ Witten Herdecke, Vest Hosp Children & Adolescents, D-45711 Datteln, Germany
[2] Univ Munich, Inst Social Pediat & Adolescent Med, Div Epidemiol, Munich, Germany
关键词
blood pressure; triacylglycerol; LDL cholesterol; HDL cholesterol; glucose; insulin; weight loss; follow-up obesity; outpatient intervention program; children; lipids;
D O I
10.1093/ajcn/84.3.490
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Data concerning the long-term improvement of cardiovascular disease (CVD) risk factors after an obesity intervention in children are limited. Objective: We studied changes in weight status and CVD risk factors in children in an intervention program and evaluated whether these changes were sustained 1 y after the end of the intervention. Design: We analyzed changes in the SD score (SDS) of body mass index [BMI; in kg/m(2) (SDS-BMI)], blood pressure (BP), lipids, and homeostasis model assessment index of insulin resistance (HOMAIR) over the course of 2 y in 240 obese (BMI > 97th percentile) children aged 6-14 y ((x) over bar age: 10.4 y; (x) over bar BMI: 26.9). Of these 240 children, 203 participated in a 1-y intervention program of physical exercise, nutrition education, and behavior therapy. We compared these children with 37 obese children who underwent no intervention and with 12 normal-weight children of the same age and sex. Results: Obese children had significantly (P < 0.05) higher BP, HOMA-IR, and insulin, triacylglycerol, and LDL-cholesterol concentrations and lower HDL-cholesterol concentrations than did normal-weight children. Twenty-nine children dropped out of the intervention. Only in the 126 children who reduced their SDS-BMI did BP (8% and 12% decreases in systolic and diastolic BP, respectively), lipids (12% and 5% decreases in triacylglycerol and LDL cholesterol, respectively; 7% increase in HDL cholesterol), insulin (13% decrease), and HOMA-IR (17% decrease) improve significantly (P < 0.05). Reduction in SDS-BMI and all benefits regarding CVD risk factors were sustained I y after the end of the intervention in the children whose SDS-BMI decreased. Conclusions: Long-term multidisciplinary intervention led to a reduction in SDS-BMI in most of the obese children 1 y after the end of the intervention. Reduction in SDS-BMI was accompanied by an improvement in CVD risk factors.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 33 条
[1]   The foods most consumed by German children and adolescents: Results of the DONALD Study [J].
Alexy, U ;
Sichert-Hellert, W ;
Kersting, M ;
Manz, F .
ANNALS OF NUTRITION AND METABOLISM, 2001, 45 (03) :128-134
[2]  
COLE TJ, 1990, EUR J CLIN NUTR, V44, P45
[3]   Efficacy and safety of statin therapy in children with familial hypercholesterolemia -: A randomized, double-blind, placebo-controlled trial with simvastatin [J].
de Jongh, S ;
Ose, L ;
Szamosi, T ;
Gagné, C ;
Lambert, M ;
Scott, R ;
Perron, P ;
Dobbelaere, D ;
Saborio, M ;
Tuohy, MB ;
Stepanavage, M ;
Sapre, A ;
Gumbiner, B ;
Mercuri, M ;
van Trotsenburg, ASP ;
Bakker, HD ;
Kastelein, JJP .
CIRCULATION, 2002, 106 (17) :2231-2237
[4]   The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation [J].
Dirisamer, A ;
Hachemian, N ;
Bucek, RA ;
Wolf, F ;
Reiter, M ;
Widhalm, K .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (06) :421-425
[5]   Childhood obesity: public-health crisis, common sense cure [J].
Ebbeling, CB ;
Pawlak, DB ;
Ludwig, DS .
LANCET, 2002, 360 (9331) :473-482
[6]   THE EFFECT OF WEIGHT CONTROL ON LIPID CHANGES IN OBESE CHILDREN [J].
EPSTEIN, LH ;
KULLER, LH ;
WING, RR ;
VALOSKI, A ;
MCCURLEY, J .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (04) :454-457
[7]   Behavioral therapy in the treatment of pediatric obesity [J].
Epstein, LH ;
Roemmich, JN ;
Raynor, HA .
PEDIATRIC CLINICS OF NORTH AMERICA, 2001, 48 (04) :981-+
[8]   Insulin resistance as a predictor of age-related diseases [J].
Facchini, FS ;
Hua, N ;
Abbasi, F ;
Raven, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3574-3578
[9]  
Hansson Lennart, 1997, Blood Pressure, V6, P365, DOI 10.3109/08037059709062096
[10]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689